Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R Baumgarten

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 1, 1992
Topical vasoconstrictor (oxymetazoline) does not affect histamine-induced mucosal exudation of plasma in human nasal airwaysC Svensson, U Pipkorn, U Alkner, et al.
British Journal of Pharmacology|February 1, 1993
Ramiprilat increases bradykinin outflow from isolated hearts of ratC R Baumgarten, W Linz, G Kunkel, et al.
Thorax|January 1, 1989
Reversibility and reproducibility of histamine induced plasma leakage in nasal airwaysC Svensson, C R Baumgarten, U Pipkorn, et al.
Allergy|November 1, 1996
Mediator release is altered in immunotherapy-treated patients: a 4-year studyD Dokic, A Nethe, J Kleine-Tebbe, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 7, 1998
Substance P is generated in vivo following nasal challenge of allergic individuals with bradykininC R Baumgarten, A O'Connor, D Dokic, et al.
Allergy|August 1, 1991
Tryptase in nasal lavage fluid after local allergen challenge. Relationship to histamine levels and TAME-esterase activityS Juliusson, K Holmberg, C R Baumgarten, et al.
The Journal of Allergy and Clinical Immunology|October 1, 1992
Substance P and beta-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthmaK Nieber, C R Baumgarten, R Rathsack, et al.
Journal of Cardiovascular Pharmacology|January 1, 1992
Bradykinin degrading activity in cultured human endothelial cellsK Graf, M Gräfe, W Auch-Schwelk, et al.
Agents and Actions. Supplements|January 1, 1992
Bradykinin and other inflammatory mediators in BAL-fluid from patients with active pulmonary inflammationC R Baumgarten, B Lehmkuhl, R Henning, et al.
Respiratory Medicine|August 5, 2000
Equivalence of as-required salbutamol propelled by propellants 11 and 12 or HFA 134a in mild to moderate asthmatics. German Study GroupC R Baumgarten, P Dorow, H H Weber, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 1, 1992
Topical vasoconstrictor (oxymetazoline) does not affect histamine-induced mucosal exudation of plasma in human nasal airwaysC Svensson, U Pipkorn, U Alkner, et al.
British Journal of Pharmacology|February 1, 1993
Ramiprilat increases bradykinin outflow from isolated hearts of ratC R Baumgarten, W Linz, G Kunkel, et al.
Thorax|January 1, 1989
Reversibility and reproducibility of histamine induced plasma leakage in nasal airwaysC Svensson, C R Baumgarten, U Pipkorn, et al.
Allergy|November 1, 1996
Mediator release is altered in immunotherapy-treated patients: a 4-year studyD Dokic, A Nethe, J Kleine-Tebbe, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 7, 1998
Substance P is generated in vivo following nasal challenge of allergic individuals with bradykininC R Baumgarten, A O'Connor, D Dokic, et al.
Allergy|August 1, 1991
Tryptase in nasal lavage fluid after local allergen challenge. Relationship to histamine levels and TAME-esterase activityS Juliusson, K Holmberg, C R Baumgarten, et al.
The Journal of Allergy and Clinical Immunology|October 1, 1992
Substance P and beta-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthmaK Nieber, C R Baumgarten, R Rathsack, et al.
Journal of Cardiovascular Pharmacology|January 1, 1992
Bradykinin degrading activity in cultured human endothelial cellsK Graf, M Gräfe, W Auch-Schwelk, et al.
Agents and Actions. Supplements|January 1, 1992
Bradykinin and other inflammatory mediators in BAL-fluid from patients with active pulmonary inflammationC R Baumgarten, B Lehmkuhl, R Henning, et al.
Respiratory Medicine|August 5, 2000
Equivalence of as-required salbutamol propelled by propellants 11 and 12 or HFA 134a in mild to moderate asthmatics. German Study GroupC R Baumgarten, P Dorow, H H Weber, et al.
Pageof 3